Hargreaves Lansdown

Polarean Imaging shares are being snapped up by investors after a big announcement from the company in late December. Ed Sheldon takes a look at the ...

The company does appear to have a lot going for it. For 2023, the company is expected to post a net loss of $14.3m. Typically, the share prices of companies this size are volatile in nature. Meanwhile, the company may need to raise capital at some point. Looking at Polarean Imaging today, there are a couple of things that stand out to me. It specialises in the use of hyperpolarized xenon gas (129Xe) as an imaging agent.